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Abstract. Amphetamine and naloxone were examined 
in place conditioning, in order to study possible interac- 
tions between endogenous opioids and catecholamines 
in reinforcement. After initial preferences were deter- 
mined, animals were conditioned with amphetamine 
alone (1.0 mg/kg SC), naloxone alone (0.02, 0.2 or 
2.0 mg/kg SC) or combinations of amphetamine plus 
naloxone. A reliable, long-lasting preference for the 
compartment associated with amphetamine was ob- 
served, reflecting the reinforcing properties of this drug. 
No preference or aversion was observed in animals that 
received saline in both compartments. Naloxone (0.02, 
0.2 and 2.0 mg/kg) produced a dose-dependent place 
aversion; while the lowest dose had effects similar to 
saline, the higher doses produced significant place aver- 
sions. Naloxone, at all three doses examined, prevented 
the ability of amphetamine to produce a place prefer- 
ence. Thus, the lowest dose of naloxone, having no ef- 
fects alone in place conditioning was still able to block 
the reinforcing effects of amphetamine. These results 
suggest that the reinforcing effects of amphetamine are 
dependent on activation of opiate receptors, and provide 
further evidence that interactions between endogenous 
opioids and catecholamines may be important in rein- 
forcement. 
Key words: d-Amphetamine - Naloxone - Place condi- 
tioning - Conditioned place preference - Reward - Rein- 
forcement - Endogenous opioids Catecholamines 
Evidence suggests that two types of neurotransmitter, 
catecholamines and endogenous opioids, may be impor- 
tant in the rewarding actions of drugs of abuse and other 
stimuli (Stein 1978; Watson etal. 1989). Catechol- 
* A preliminary report of this research was presented at the 1 lth 
Annual Society for Neuroscience Meeting in Dallas, Texas (Trujillo 
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amines, particularly dopamine, appear to mediate the 
reinforcing properties of the psychomotor stimulants 
amphetamine and cocaine, while opiate drugs produce 
reinforcement by mimicking the actions of endogenous 
opioids at opioid receptors. Additionally, studies suggest 
that opioids and catecholamines, and the drugs that af- 
fect these systems, may interact in reward processes. De- 
pletion of catecholamines with alpha-methyl paratyro- 
sine prevents self-administration of morphine (Davis 
and Smith 1973) and suppresses the potentiating effects 
of morphine on self-stimulation (Pert and Hulsebus 
1975). Dopamine receptor antagonists have been ob- 
served to block the reinforcing actions of opiates in place 
preference conditioning (Bozarth and Wise 1981 ; Phillips 
et al. 1982; Spyraki et al. 1983; Shippenberg and Herz 
1987; Hand et al. 1989; however see also Mackey and 
van der Kooy 1985). Synergistic effects have been ob- 
served on self-stimulation behavior when morphine and 
amphetamine are injected together, suggesting a potent 
interaction between these compounds in reinforcement 
(Hubner et al. 1987). The opioid receptor antagonist na- 
loxone blocks the facilitation of rate (Holtzman 1976; 
Franklin and Robertson 1982; Trujito et al. 1983) and 
the decrease in threshold (Esposito et al. 1980) produced 
by amphetamine in self-stimulation and potentiates the 
threshold-increasing effects of chlorpromazine (Esposito 
et al. 1981). More recently, opiate antagonists have been 
found to block the cocaine-induced decrease in self-stim- 
ulation threshold (Bain and Kornetsky 1986) and to alter 
the self-administration of cocaine in a manner consistent 
with a decrease in reinforcement (Carroll et al. 1986; 
De Vry et al. 1989). It thus appears that opioids and 
catecholamines interact in positive reinforcement, and 
it may well be that there is an interdependence of these 
neurotransmitter systems in reward function (Belluzzi 
and Stein 1977; Maroli etal. 1978; Broekkamp et al. 
1979; Bozarth and Wise 1981; Esposito et al. 1981; Bo- 
zarth 1983; Bain and Kornetsky 1986; Watson etal. 
1989). 
The place conditioning paradigm has attracted con- 
siderable attention in recent years as a valuable method 
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for assessing the reinforcing actions of drugs (see Bo- 
zarth 1987; van der Kooy 1987; Carr et al. 1989; Hoff- 
man 1989 for reviews). In this paradigm, administration 
of a drug is paired with a distinct set of environmental 
cues during conditioning trials. The reinforcing or aver- 
sive properties of the drug are determined by assessing 
whether the subject approaches or avoids the drug- 
paired environment after conditioning. The place condi- 
tioning paradigm has been useful in examining the rein- 
forcing properties of opiate drugs (Rossi and Reid 1976; 
Bozarth and Wise 1981 ; van der Kooy et al. 1982; Ship- 
penberg and Herz 1987; Shippenberg et al. J988, 1989), 
opioid peptides (Katz and Gormenzano 1979; Stapleton 
et al. 1979; Phillips and LePiane 1982; Glimcher et al. 
1984a; Almaric et al. 1987), and psychomotor stimu- 
lants (Reicher and Holman 1977; Sherman et al. 1980; 
Spyraki et al. 1982a, b; Gilbert and Cooper 1983), as 
well as a variety of other compounds (Glimcher et al. 
1984a, b; Fudala et al. 1985; Spyraki et al. 1985; File 
1986). In addition, this method has proven valuable in 
studying interactions between drugs and the neurotrans- 
mitter systems they affect (Bozarth and Wise 1981 ; Spy- 
raki etal. 1982a, b; 1983; 1987; 1988; Carboni etal. 
1989; Houdi et al. 1989). 
In the present studies, amphetamine and naloxone 
were examined alone and in combination in place condi- 
tioning, in order to determine possible interactions be- 
tween endogenous opioids and catecholamines in rein- 
forcement. 
Materials and methods 
Animals. One hundred and forty-one experimentally naive, male, 
Sprague-DawIey rats (Charles River) were used. Animals weighed 
250-350 g at the start of  experiments, and were housed in groups 
of three to five in stainless steeI cages on a 12 h light/dark cycle, 
with food and water available ad lib. 
Apparatus. Two identical Plexiglas shuttle boxes (80 x 25 x 30 cm), 
divided into three distinct compartments, were used for experi- 
ments. The shuttle boxes had clear ceilings and consisted of two 
large compartments (35 × 25 cm) separated by stainless steel guillo- 
tine doors from a smaller central compartment (J0 x 25 cm). One 
of the large compartments had black walls, a stainless steel grid 
floor, and sawdust litter below the floor; the other had white walls, 
a wire mesh floor, and corncob litter below the floor. The central 
compartment had one black wall containing a 9 cm wide opening 
into the black compartment, one white wall containing a 9 cm 
wide opening into the white compartment, and two gray walls; 
guillotine doors blocking the openings could be removed to allow 
the animal access to the entire shuttle box. A microswitch mounted 
beneath the floor of each compartment detected when the animal 
was in that compartment. The number of entries into, and the 
amount of time spent within each compartment was automatically 
recorded by a computer interfaced with the shuttle boxes via a 
BRS-LVE Interact system. During experiments the testing room 
was dimly lit by fluorescent fixtures mounted on the ceiling. A 
single speaker positioned at the rear of the middle chamber deliv- 
ered white noise. 
Drugs. Drugs tested were d-amphetamine sulfate alone (1.0 mg/kg), 
naloxone HC1 alone (0.02, 0.2, and 2.0 mg/kg), or combinations 
of amphetamine plus each of  the three doses of  naloxone, delivered 
in a single injection. Drugs were dissolved in sterile saline and 
administered subcutaneously (SC) in a volume of 1.0 ml/kg imme- 
diately before placing the animal in the shuttle box. 
General procedure. Animals were weighed and handled for at least 
1 week prior to experiments. Experiments began with 3 oi" 4 precon- 
ditioning test days: each animal was placed in the central compart- 
ment and the guillotine doors immediately removed, giving the 
animal access to the entire shuttle box for 15 rain. The amount 
of time spent by each rat in the two large compartments on the 
final preconditioning day was used as a measure of initial prefer- 
ence. The following 8 days served as the conditioning phase: on 
alternate days each animal was injected with drug and confined 
to one of the large compartments, or injected with saline and con- 
fined to the opposite compartment, for 30 rain. The order of injec- 
tion was counterbalanced across rats. Control animals received 
saline injections in both compartments. The final phase of the ex- 
periment was the postconditioning preference determination, and 
was identical to the preconditioning test days: each animal was 
placed in the central compartment (without injection) and again 
given access to the entire apparatus for 15 rain, during which the 
time spent in each compartment was automatically recorded. 
Throughout all phases of experiments, the black compartment was 
wiped thoroughly with a dilute ethanol solution, and the white 
compartment with a dilute soap solution immediately prior to ex- 
posing each animal to the shuttle box, in order to further distin- 
guish these compartments; the central compartment was wiped 
clean with distilled water in order to remove the odor of the pre- 
vious animal. The conditions of the shuttle boxes established a 
balanced choice situation for the rats. While each rat had an indi- 
vidual preconditioned bias for one compartment over the other, 
there was no bias tbr the group as a whole; half the rats preferred 
the white compartment and half preferred the black compartment 
at the beginning of experiments (see Results). 
Experiment I procedure. Amphetamine place conditioning. Amphet- 
amine place conditioning was examined in two studies. Experiment 
1 a determined the ability of amphetamine to produce a preference 
for the initially non-preferred compartment, and compared these 
affects to those of saline. After the preconditioning preference de- 
termination, amphetamine-conditioned animals (n = 9) received, on 
alternate days, amphetamine in the initially non-preferred compart- 
ment or saline in the initially preferred compartment. Control ani- 
mals (n = 7) received saline treatment in both compartments (the 
initially non-preferred compartment was designated as the drug- 
paired compartment for comparison with amphetamine-treated an- 
imals). Preference was determined on day 1 and on day 7 after 
conditioning. Experiment 1 b compared amphetamine condition- 
ing in the initially non-preferred compartment with amphetamine 
conditioning in the initially preferred compartment. This compari- 
son allows one to rule out certain non-specific factors, such as 
a non-contingent shift in preference, that might potentially be in- 
volved in place conditioning (Spyraki et al. 1985; Carr et al. 1989). 
After the preconditioning preference determination, one group of 
animals (n=10) received amphetamine in the initially non-we- 
ferred compartment and saline in the initially preferred compart- 
ment, while a second group (n= 16) received amphetamine in the 
initially preferred compartment and saline in the initially non-we- 
ferred compartment, on alternate days. A third group (n=8) re- 
ceived saline in both compartments (as above, the initially non- 
preferred compartment was designated as the drug-paired compart- 
ment for comparison with amphetamine-treated animals). 
Experiment 2 procedure. Naloxone place conditioning. This experi- 
ment examined the ability of naloxone to produce a conditioned 
place aversion. Following the preconditioning preference determi- 
nation, animals (n = 8 per group) received, on alternate days, nalox- 
one (0.02, 0.2, or 2.0 mg/kg) in the initially preferred compartment 
or saline in the initially non-preferred compartment. For compari- 
son and control, a fourth group received naloxone (2.0 mg/kg) 
in the initially non-preferred compartment, and saline in the initial- 
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ly preferred compartment. As noted above, this control group al- 300- 
lows one to determine whether certain non-specific factors might 
N play a role in the place conditioning experiment. --  200- 
Experiment 3 procedure. Place conditioning with naloxone and am- 
phetamine. Interactions between amphetamine and naloxone in uJ lO0- 
place conditioning were examined in this experiment. In particular, 
we were interested in whether the opiate antagonist naloxone might m'~ 
interfere with the conditioned place preference produced by am- 
phetamine. During conditioning, animals received amphetamine 
(1.0 mg/kg) and naloxone (2.0 mg/kg, n = 11 ; 0.2 mg/kg, n = 8 ; or ~" -t00- 
0,02 mg/kg, n= 16) administered together in a single injection in 
the initially non-preferred compartment, or saline administered in m 
the initially preferred compartment, on alternate days. For compar- ~ -200- 
±son and control, a fourth group (n=24) was conditioned with m 
amphetamine (1.0 mg/kg) and naloxone (0.02 mg/kg) in the initial- 
ly preferred compartment, alternated with saline in the initially 
non-preferred compartment 
Data analysis. The difference between the amount of time spent 
in the drug-paired compartment and the saline-paired compart- 
ment was used as the preference measure (thus, for animals condi- 
tioned in the initially non-preferred compartment, the initial prefer- 
ence is seen as a negative number; for animals conditioned in the 
initially preferred compartment the initial preference is seen as a 
positive number). This method of preference determination, which 
has been used in a number of studies (Mucha et al. 1982, 1985; 
Mucha and Iversen 1984; Mucha and Herz 1985; Bechara et al. 
1987; Shippenberg and Herz 1987; Shippenberg et al. 1988, 1989; 
Bechara and van der Kooy 1989), offers an excellent graphical 
and statistical representation of preference and aversion in the shut- 
tle box. Group means were obtained, and overall significance deter- 
mined by two-factor repeated measures analysis of variance (drug 
treatment versus test day) where applicable. For individual treat- 
ments the preconditioned preference (or initial preference) was 
compared to the post-conditioned preference by a paired t-test. 
Differences between saline and drug treatments, or between differ- 
ent drug treatments, were compared using unpaired t-tests, or one- 
way analysis of variance followed by Dunnett's t-test. Reinforcing 
or avers±re properties were determined by the ability of a drug 
to reverse or strengthen the initial preference of the animals for 
the drug-paired compartment. In addition to preference determina- 
tions, the number of entries into each compartment was quantified 
as a measure of locomotor activity within the apparatus. 
Results 
In the present  studies an " u n b i a s e d "  or  " b a l a n c e d "  
shuttle box  was used. A l though  each rat  individually 
had an initial bias, there was no overwhelming prefer- 
ence for  one c o m p a r t m e n t  over  the other.  This is re- 
flected by  the fact that  approximate ly  ha l f  the rats used 
in these experiments preferred the black c o m p a r t m e n t  
( 7 7 / 1 4 1 = 5 5 % ) ,  and approximate ly  hal f  preferred the 
white c o m p a r t m e n t  (64/141 = 4 5 % )  pr ior  to condi t ion-  
ing. 
Two factor  repeated measures analysis o f  variance 
o f  experiment  1 a revealed a significant effect o f  drug 
t rea tment  (P  < 0.01), a significant effect o f  test day  (P  < 
0.001), and a non-signif icant  interact ion ( P =  0.06). Am-  
phetamine,  paired with the initially non-prefer red  com-  
par tment ,  caused a significant shift in preference to this 
compa r tmen t  (p recond i t ion ing=- -182 .1_+45 .5 ,  post-  
condi t ioning  = 203.3 + 72.2, n = 9, P < 0.001). This pref- 
erence was  mainta ined  when animals were retested after 
7 unhand ted  days in their h o m e  cages (7 days = 222.3-I- 
- - r a m  
=91 
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Fig. 1. Effects of amphetamine and saline in place conditioning. 
Amphetamine (AMPHET) paired with the initially non-preferred 
compartment caused animals to shift their preference to this com- 
partment. Animals retained this altered preference when retested 
7 days later. Saline paired with both compartments caused a non- 
significant shift to a non-preference for either compartment, which 
was not retained when animals were retested 7 days later. Scores 
represent number of seconds in the drug-paired compartment min- 
us number of seconds in the saline-paired compartment (for saline 
animals, the initially non-preferred compartment was designated 
as the drug-paired compartment). PRE=preconditioning prefer- 
ence; POST= postconditioning preference 
59.1; Fig. t). Saline, paired with bo th  compar tmen t s  
caused a non-signif icant  shift to  a non-preference for  
either c o m p a r t m e n t ;  i.e., a preference o f  zero (precondi-  
t ioning = - 217.9 ± 77.4, pos tcondi t ion ing  = 0.6 ± 46.4, 
n = 7, n.s.). W h e n  retested after 7 days,  there was a ten- 
dency for  saline animals  to return to precondi t ioned 
preferences, a l though  the effect was no t  significant (7 
days = - 138.0 ± 64.6; Fig. 1). Unpa i red  t-test analyses 
o f  the saline and amphe tamine  g roup  showed no signifi- 
cance difference between the groups  at the precondi t ion-  
ing test, but  a significant difference at the first pos tcondi-  
t ioning test ( P <  0.025), and at the 7-day test ( P <  0.005). 
These experiments were highly replicable - effects in ex- 
per iment  1 b were nearly identical to those in experiment  
I a [ two-factor  repeated measures A N O V A :  drug treat- 
ment  (P<0 .001 ) ,  test day  ( P < 0 . 0 0 2 ) ,  interact ion ( P <  
0.002); paired t-test analysis o f  d rug  t rea tments :  am-  
phe tamine  precondi t ioning = - t 35.6 + 27.5, pos tcondi -  
t ioning = 189.4 +_ 55.3, n = 10, P < 0.001 ; saline precondi-  
t ioning = - 115.2 ± 6.3, pos tcondi t ion ing  = - 20.6 ± 
51.8, n =  8, n.s.; Fig. 2). W h e n  amphe tamine  was paired 
with the initially preferred compar tment ,  no shift in pref- 
erence was observed;  animals mainta ined  their prefer- 
ence for  this compa r tmen t  (precondi t ioning=167.9_+ 
36.9, p o s t c o n d i t i o n i n g =  168.1 _41 .9 ,  n =  16, n.s.; 
Fig. 2), demons t ra t ing  that  they preferred the compar t -  
ment  associated with amphe tamine  whether  it was the 
initially non-preferred compa r tmen t  or  the initially pre- 
ferred compar tmen t .  Compar i son  o f  the three drug  
treatments  on  the pos tcondi t ion ing  day  (one-way A N O -  
VA, followed by Dunne t t ' s  t-test) revealed tha t  the saline 
g roup  was significantly different f r o m  amphetamine ,  
whether  amphe tamine  was paired with the initially non-  
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Fig. 2. Replicability of amphetamine and saline in place condition- 
ing; effects of amphetamine conditioned in the initially preferred 
compartment. The effects of amphetamine (AMPHET) paired with 
the non-preferred compartment, and saline paired with both com- 
partments were qualitatively and quantitatively very similar to 
those seen in Fig. 1 - amphetamine caused a significant shift to 
the drug-paired compartment, while saline caused a non-significant 
shift to a non-preference for either compartment. When amphet- 
amine was paired with the initially preferred compartment, animals 
maintained their preference for this compartment. Scores represent 
number of seconds in the drug-paired compartment minus number 
of seconds in the saline-paired compartment (for saline animals, 
the initially non-preferred compartment was designated as the 
drug-paired compartment). PRE= preconditioning preference; 
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Fig. 3. Naloxone causes a dose-dependent place aversion. Saline 
data is the same as seen in Fig. 1, inverted for comparison with 
the naloxone scores (when saline is injected in both compartments, 
either compartment may be designated as the '°drug side"). The 
saline data is shown for visual comparison only - these data were 
not included in the statistical analysis. Naloxone 0.02 mg/kg paired 
with the initially preferred compartment did not cause a significant 
shift in preference. Naloxone 0.2 mg/kg and naloxone 2.0 mg/kg 
paired with the initially preferred compartment each caused a sig- 
nificant shift in preference away from this compartment. Naloxone 
2.0 mg/kg paired with the initially non-preferred compartment 
caused this compartment to be even less preferred. Scores represent 
number of  seconds in the drug-paired compartment minus number 
of seconds in the saline-paired compartment. PRE=precondition- 
ing preference; POST= postconditioning preference 
preferred compar tment  (P<0.025)  or paired with the 
initially preferred compar tment  (P < 0.025). 
Naloxone caused a shift in preference away from the 
initially preferred compar tment  (Fig, 3). Two factor re- 
peated measures analysis of  variance showed no signifi- 
cant effect of  treatment,  a highly significant effect of  
test day (P<0.001) ,  and a significant interaction ( P <  
0.005). While 0.02 mg/kg naloxone, paired with the ini- 
tially preferred compartment ,  did not  cause a significant 
shift in preference (preconditioning = 98.0_+ 23.0, post- 
condi t ioning=10.4 _+ 46.3, n = 8 ,  n.s.), 0 .2mg/kg  and 
2.0 mg/kg produced successively greater shifts in prefer- 
ence away f rom this compar tment  (0.2 mg/kg precon- 
ditioning = 222.8 +_ 80.4, postconditioning = - 135.0 _+ 
103.7, n = 8 ,  P < 0 . 0 5 ;  2 .0mg/kg  precondi t ioning= 
237.0_+84.8, pos tcondi t ion ing=-325 .2__74 .2 ,  n = 8 ,  
P<0.001) ,  al though the difference between 0.2 and 
2.0 mg/kg was not  statistically significant. Naloxone 
(2.0 mg/kg) paired with the initially non-preferred com- 
par tment  caused this compar tment  to be even less pre- 
ferred, demonstrat ing that this drug produces aversion 
independent of  the side of  conditioning (precondition- 
ing = - 235,8 +_ 92.6, postconditioning = - 357.2 +_ 89.4, 
n = 8 ,  P<0 .02) .  
Animals conditioned with the combinat ion of  am- 
phetamine (1.0mg/kg)  plus naloxone (0.02, 0.2 or 
2.0 mg/kg) in the initially non-preferred compar tment  
showed no significant change in preference (amphet- 
amine 1.0 mg/kg plus naloxone 2.0 precondi t ioning= 
- 156.3 __ 54.2, postconditioning = - 103.6 + 72.2, n = 
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Fig. 4. Naloxone prevents the ability of amphetamine to cause a 
shift in place preference. When amphetamine (AM) and naloxone 
(NAL), administered together in a single injection, were paired 
with the initially non-preferred compartment, a non-significant 
shift toward a non-preference for either compartment was ob- 
served. When amphetamine and 0.02 mg/kg naloxone were paired 
with the initially preferred compartment, a non-significant shift 
toward a non-preference for either compartment was observed. 
Scores represent number of seconds in the drug-paired compart- 
ment minus number of seconds in the saline-paired compartment. 
PRE = preconditioning preference; POST= postconditioning pref- 
erence 
t ioning-- - 219.6___ 60.0, postconditioning = - 157.1 _+ 
57.0, n = 8 ,  n.s.; amphetamine 1.0 plus naloxone 0.02 
precondi t ioning= - 133.1 _+ 35.8, postcondi t ioning= - 
92.5 _+ 82.2, n = 16, n.s.), suggesting that  naloxone inter- 
feres with the ability of  amphetamine to produce a place 
Table 1. Effects of place conditioning on locomotor behavior. 
Values represent the mean number of entries _+ SEM into the drug- 
paired and saline-paired compartments, before and after condition- 
ing, for each experimental treatment. The compartment which was 
paired with drug is shown in column 2: NPref= drug was paired 
with the initially non-preferred compartment; Pref=drug was 
paired with the initially preferred compartment (in the saline con- 
trol experiment, saline was paired with both compartments, how- 
ever the initially non-preferred compartment is designated as the 
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drug-paired compartment). The number of animals is shown in 
parentheses. Numbers in brackets represent the postconditioning 
locomotor behavior expressed as percent of preconditioning. * Sig- 
nificant difference (P<0.05, paired t-test) in locomotor behavior 
between the preconditioning test (pre) and the postconditioning 
test (post). ? Significant difference (P<0.05, paired t-test) between 
the drug-paired and saline-paired compartments at postcondition- 
ing test 
Treatment Conditioned Drug Saline 
compartment 
Saline Both Pre 14.1 + 1.4 14.8 + 1.3 
(n= 16) Post 17.3_+2.6 [1221 17.7_+2.3 [120] 
Amphetamine 1.0 NPref Pre 13.5 + h 1 15.7_+ 0.8 
(n= 19) Post 17.2_+ 1.2 [1271" 15.0_+ 1.I [96] 
Pref Pre 15.7 _+ 1.7 11.6 _+ 1.6 
(n= 16) Post 22.5_+2.4 [143]* 19.6_+3.7 [169]* 
Naloxone 0.02 Pref Pre 11.2 _+ 1.4 11.9 __% 1.3 
(n = 8) Post ].6.6 _+ 2.7 [148] 18.6 + 3.6 [156] 
Naloxone 0.2 Pref Pre 10.6 -+ 2.0 10.0 + 2.1 
(n = 8) Post 10.0 __% 2.2 [94] 15.5 -+ 3.8 [155] 
Naloxone 2.0 Pref Pre 14.1 + 2.0 11.6 _+ 2.1 
(n = 8) Post 4.8 + 1.2 [34] * 14.6__% 3.6 [126] "t" 
NPref Pre 9.2-+ 1.5 11.6 +_% 2.1 
(n = 8) Post 6.0 -+ 1.4 [651 * 12.t _+ 1.8 [1041 ? 
Am 1.0+Nal 0.02 Pref Pre 13.8 + 1.2 10.5 _+ 1.0 
(n = 24) Post 14.6 + 1.5 [106] 13.0 -+ 1.8 [124] 
NPref Pre 14.5 _+ 2.2 15.1 _+ 1.7 
(n = 16) Post 13.2_+ 2.4 [91] 15.6 + 1.8 [103] 
Am 1.0 + Nal 0.2 NPref Pre 9.9 + 1.9 14.9 -+ 3.0 
(n=8) Post 11.2_+1.1 [113] 19.2_+2.7 [129]*? 
Am 1.0 + Nal 2.0 NPref Pre 13.5 _+ 2.6 16.5 + 3.1 
(n=l l)  Post 8.3_+1.8 [61] 14.3-+1.9 [87]? 
preference (Fig. 4). Note that  even the lowest dose of  
naloxone (0.02 mg/kg), which lacked aversive effects on 
its own, still had the ability to block the place condition- 
ing effects of  amphetamine.  When the combinat ion of  
0.02 mg/kg naloxone plus 1.0 mg/kg amphetamine was 
injected in the initially preferred compar tment ,  the re- 
sults were very similar to saline conditioning; the shift 
was toward a non-preference for either compar tment  
(preconditioning = 168.9 _ 31.5, postconditioning = 
37.1 _+ 74.3, n = 24, n.s.; Fig. 4). There was no significant 
difference between any of  the treatments at the postcon- 
ditioning test. 
In the present studies we assessed locomotor  activity 
by measuring compar tment  entries during testing, both  
before and after conditioning. The number  of  compar t -  
ment  entries is not  only a good measure of  locomotor  
activity within the shuttle box, but also an excellent mea- 
sure of  activity within each compartment .  This was dem- 
onstrated in a recent study by Neisewander et al. (1990), 
who found a very high correlation between the number  
of  entries into a compar tment  and the number  of  line 
crossings within that  compar tment  (r = 0.90, P < 0.005 
for data  shown in Table 1 of  their paper). The effect 
o f  place conditioning on compar tment  entries for the 
present experiments are shown in Table 1. The general 
tendency observed was a non-significant increase in total 
entries for most  treatments,  including saline control ani- 
mals. These increases were typically observed in both 
the drug-paired and saline-paired compartments ,  sug- 
gesting that conditioning may  lead to a mild, non-selec- 
tive increase in locomotor  activity within the shuttle box. 
Significant increases in entries into the drug-paired com- 
par tment  were observed when amphetamine  was paired 
with the initially non-preferred compar tment ,  into both 
compar tments  when amphetamine was paired with the 
initially preferred compartment ,  and into the saline- 
paired compar tment  when amphetamine  and naloxone 
(0.2 mg/kg) were paired with the initially non-preferred 
compartment .  By far, the most  robust  effect on compar t -  
ment  entries was in naloxone-treated animals. The high- 
est dose of  naloxone (2.0 mg/kg) produced significant 
decreases in compar tment  entries when paired with ei- 
ther the initially preferred or the initially non-preferred 
compartment .  The only treatments which produced sig- 
nificant differences in compar tment  entries between the 
drug-paired and saline paired compar tments  were nalox- 
one (2.0 mg/kg) paired with either compar tment ,  and 
naloxone (0.2 or 2.0 mg/kg) and amphetamine  paired 
with the initially non-preferred compared.  In each of  
these cases the drug-paired compar tment  had signifi- 
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cantly fewer entries than the saline-paired compartment. 
Thus, beyond the decrease in entries into the drug-paired 
compartment for animals receiving high doses of nalox- 
one, these results demonstrate no consistent relationship 
between locomotor activity and place conditioning. 
Discussion 
Repeated pairings of a distinctive environment with am- 
phetamine caused animals to prefer that environment 
over an alternative environment associated with saline, 
confirming previous reports of the effects of amphet- 
amine in place conditioning (see Carr et al. 1989; Hoff- 
man 1989 for review). The place conditioning produced 
by amphetamine was both highly replicable and persis- 
tent, remaining at least 7 days after conditioning. More- 
over, when amphetamine was paired with the initially 
preferred compartment, this compartment was still pre- 
ferred after conditioning. These results demonstrate that 
amphetamine did not cause a non-specific shift in prefer- 
ence, but instead that animals preferred the compart- 
ment associated with this drug regardless of whether 
the compartment was the initially preferred or the initial- 
ly non-preferred environment. Although amphetamine 
did not produce an increase in preference for the initially 
preferred compartment, evidence suggests that the re- 
sults represent a valid conditioned place preference; 1) 
in contrast to saline control groups a strong preference 
was maintained for the drug-paired compartment after 
conditioning, 2) the magnitude of the post-conditioning 
preference score was virtually identical to the score for 
animals conditioned with amphetamine in the initially 
non-preferred compartment, and 3) the results for these 
animals were significantly different from saline. Thus, 
although no increase in preference was observed for ani- 
mals conditioned with amphetamine in the initially pre- 
ferred compartment, the fact that the preference score 
remained highly positive is significant. 
Interestingly, when saline was paired with both com- 
partments, a slight, non-significant shift in preference 
was observed. However, this shift was not a change in 
preference to the opposite compartment as seen with 
amphetamine, but a shift to a non-preference for either 
compartment; i.e. a preference of zero. Although the 
shift was not significant in either experiment, evidence 
suggests that the effect is reliable. First, when the data 
for the two saline experiments is combined, the effect 
closely approaches statistical significance (P-- 0.06). Sec- 
ond, a similar non-significant shift was observed in ani- 
mals treated with the low dose of naloxone (0.02 mg/kg) 
when this dose was administered None, or when it was 
administered with amphetamine. The elimination of un- 
conditioned biases with saline or very low doses of na- 
loxone may represent habituation of the animals to the 
two compartments. Each animal, in the course of the 
experiments, was confined to each compartment for four 
30-min sessions. This confinement may have led to habit- 
uation of those cues that caused the animal to prefer 
one environment over the other prior to injections. It 
is interesting to note that there was a tendency for saline- 
treated animals to return to preconditioned preferences 
when retested 7 days later. It may be that a week without 
exposure to the apparatus allows the extinction of habit- 
uation and the reestablishment of unconditioned prefer- 
ences. Future studies should help to elucidate the reli- 
ability and significance of the effects seen in animals 
receiving saline in both compartments. 
Naloxone, in the present studies, caused animals to 
avoid the compartment associated with this drug, in a 
dose-dependent manner. While the effects of 0.02 mg/kg 
were similar to those of saline, the higher doses produced 
significant place aversions. In parallel with the amphet- 
amine experiments, conditioning occurred independent 
of which compartment was paired with drug - animals 
avoided the naloxone-paired compartment whether this 
drug was paired with the initially preferred environment 
or the initially non-preferred environment, suggesting 
that this effect was a specific place aversion, rather than 
a non-specific change in compartment preference. In pre- 
vious studies, conflicting results have been reported, with 
some studies observing place aversion with naloxone 
(Mucha et al. 1982, 1985; Mucha and Iversen 1984; Be- 
chara and van der Kooy 1985; Mucha and Herz 1985), 
and other studies obtaining no effects of this drug in 
place conditioning (Phillips and LePiane 1980, 1982; Bo- 
zarth and Wise 1981). It has been suggested that the 
lack of effects in the latter studies resulted from insensi- 
tive procedures used by the investigators (Mucha and 
Iversen 1984). Significantly, the effects observed for na- 
loxone in the present experiments were strikingly similar 
to those reported in two previous studies (Mucha et al. 
1982; Mucha and Iversen 1984). 
Animals injected with combinations of amphetamine 
plus naloxone in the initially non-preferred compartment 
showed no significant change in place preference, in an 
apparent blockade of amphetamine place conditioning 
by naloxone. However, since the 0.2 and 2.0 mg/kg doses 
of naloxone alone produced place aversions, it cannot 
be concluded that these doses simply blocked amphet- 
amine conditioning - the interaction may have resulted 
from an algebraic summation of the negative effects of 
naloxone and the positive effects of amphetamine in 
place conditioning. On the other hand, since no aversive 
effects were detected with 0.02 mg/kg naloxone, it ap- 
pears that this dose selectively blocked the place condi- 
tioning actions of amphetamine. An alternate possibility 
is that the combination of naloxone plus amphetamine 
was aversive to the animals. Despite the lack of effect 
of 0.02 mg/kg naloxone alone in place conditioning, it 
is possible that this dose in combination with amphet- 
amine was aversive. However, animals conditioned with 
this combination showed effects very similar to saline 
- a shift toward a non-preference for either compart- 
ment, regardless of whether the conditioning took place 
in the initially preferred or the initially non-preferred 
compartment. The fact that these effects were very simi- 
lar to those of saline suggests that the low dose of nalox- 
one produced a simple blockade of amphetamine-depen- 
dent place conditioning. It is important to emphasize 
the low dose required for this blockade. The 0.02 mg/kg 
dose of naloxone is 10 fold tess than the dose required 
to suppress self-stimulation behavior (Trujillo etal. 
27t 
1983, 1989a, b), and 500 fold less than the dose required 
to suppress locomotion (DeRossett and Hottzman 1982). 
As noted above, results in place conditioning experi- 
ments are commonly interpreted as reflecting the re- 
warding or aversive properties of the drug(s) under 
study. It has been suggested, however, that the place 
conditioning paradigm may be confounded for drugs, 
such as amphetamine, which alter locomotor behavior 
(Swerdtow and Koob 1984). According to this sugges- 
tion, the amphetamine place preference observed in the 
present study may have been an artifact of increased 
locomotion in the drug-paired compartment. Moreover, 
the blockade of amphetamine place preference by nalox- 
one may have resulted from naloxone blockade of am- 
phetamine-dependent locomotion (Hitzemann etal. 
1982; Holtzman 1974; Swerdlow et al. 1985). Several 
studies, however, have demonstrated that locomotor ac- 
tivity does not contribute significantly to place prefer- 
ence conditioning, and thereby dispute the suggestion 
that drug-induced place preferences are artifacts of alter- 
ations in locomotion (DiScala et al. 1985; Martin-Iver- 
son et al. 1985; Mithani et al. 1986; Bozarth 1987; Ve- 
zina and Stewart 1987; Carr et al. 1988, 1989; Costello 
etal. 1989; Shippenberg etal. 1989). In the present 
studies we measured locomotion in the shuttle box dur- 
ing testing and found no consistent relationship between 
this behavior and amphetamine-induced changes in 
place preference. Although the present data cannot com- 
pletely rule out the possibility that the place conditioning 
resulted from drug-induced changes in locomotion, the 
above noted studies, together with our data on locomo- 
tor behavior, support our suggestion that the present 
results are indeed a valid reflection of the motivational 
properties of amphetamine and naloxone, rather than 
a locomotor artifact. Further, although it is presently 
unclear whether the place conditioning paradigm mea- 
sures the same aspects of reward as the self-administra- 
tion or self-stimulation experiments, most investigators 
agree that this methodology is a legitimate tool for ex- 
amining the rewarding properties of drugs (Bozarth 
1987; van der Kooy 1987; Carr et al. 1989; Hoffman 
1989). 
Regarding possible explanations for the blockade of 
amphetamine reward by naloxone, it must first be con- 
sidered that this effect might result from a non-specific 
chemical or pharmacokinetic interaction; i.e., naloxone 
might alter the absorption or distribution of amphet- 
amine in the body, preventing this drug from reaching 
the brain. If such a mechanism were responsible for the 
effects of naloxone, then one might predict that this drug 
should similarly affect different psychoactive actions of 
amphetamine. However, naloxone has been reported to 
affect some of amphetamine's actions but not others. 
Holtzman (1974) observed that naloxone reduced the 
stimulatory effects of amphetamine on avoidance re- 
sponding and locomotor activity, but not amphet- 
amine's effects on food intake or body temperature. 
Likewise, Haber and coworkers (Haber et al. 1978), and 
Hitzemann et al. (1982) observed that naloxone selec- 
tively blocked amphetamine-stimulated rearing behavior 
without affecting amphetamine-dependent hyperactivity 
or stereotypy. In addition, naloxone has been observed 
to attenuate amphetamine-dependent facilitation of dor- 
sal tegmental self-stimulation, but not self-stimulation 
of the prefrontal cortex (Franklin and Robertson 1982). 
It should be noted that different actions of naloxone 
on different amphetamine-dependent behaviors does not 
unequivocally rule out a non-specific pharmacokinetic 
interaction. For example, if naloxone simply decreased 
the concentration of amphetamine reaching the brain, 
then this drug might interfere with behaviors dependent 
on a high dose of amphetamine, but not behaviors re- 
quiring a low dose. Nevertheless, the fact that naloxone 
interferes with very closely related behavioral actions 
of amphetamine, i.e. amphetamine-dependent rearing, 
but not hyperactivity or stereotypy, and selectively atten- 
uates the effects of amphetamine on self-stimulation of 
one brain site but not another, lead us to believe that 
the present results were not due to a non-specific phar- 
macokinetic interaction. Moreover, if naloxone non-spe- 
cifically interfered with the absorption or distribution 
of amphetamine in the body, then one might expect that 
this drug would also affect the pharmacokinetics of a 
variety of other drugs. However, the effects of naloxone 
are limited to remarkably few actions and interactions 
(cf. Andrews and Holtzman 1988). Naloxone blockade 
of amphetamine place conditioning, therefore, more 
likely results from a specific neural interaction between 
these drugs. 
Although the site of interaction between naloxone 
and amphetamine is presently unknown, evidence sug- 
gests that the nucleus accumbens is a likely candidate. 
Studies suggest that amphetamine has its reinforcing ac- 
tion by releasing dopamine from mesolimbic nerve ter- 
minals in this nucleus (Lyness et al. 1979; Monaco et al. 
1981; Spyraki etal. 1982b; Aulisi and Hoebel 1983). 
Additionally, receptor binding studies have demon- 
strated that opioid receptors are located on mesolimbic 
dopamine neurons (Pollard et al. 1977). Naloxone has 
been observed to antagonize the amphetamine-stimu- 
lated release of 3H-dopamine (Hitzemann et al. 1982), 
and the amphetamine-dependent decrease of the dopa- 
mine metabolite, homovanillic acid, in the nucleus ac- 
cumbens (Applegate et al. 1982). Therefore, naloxone 
may prevent amphetamine reward by blocking opiate 
receptors on mesolimbic dopamine neurons, interfering 
with amphetamine-stimulated release of dopamine. Re- 
gardless of the specific neural mechanism responsible, 
however, the present results demonstrate that activation 
of opioid receptors may play an important role in the 
ability of amphetamine to establish a conditioned place 
preference. 
It is notable that opiate antagonists have been ob- 
served to interfere with amphetamine in a variety of 
behavioral tests, including continuous avoidance re- 
sponding and locomotor activity (Holtzman 1974; Swer- 
dlow et al. 1985; Andrews and Holtzman 1987; Winslow 
and Miczek 1988), rearing behavior (Haber et al. 1978; 
Hitzemann et al. 1982), turning behavior (Dettmar et al. 
1978), and acquisition and consolidation of memory 
(Fulginiti and Cancela 1983). More important to the 
present results, however, are findings of interactions be- 
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tween naloxone and amphetamine in self-stimulation ex- 
periments. Several investigators have reported that na- 
loxone prevents the facilitating effect of amphetamine 
on self-stimulation, suggesting that blockade of opioid 
receptors intereferes with the reinforcing actions of am- 
phetamine (Holtzman 1976; Esposito et al. 1980; Leith 
1982; Trujitlo et al. 1983). The present results support 
this possibility, providing further evidence that activa- 
tion of opioid receptors may be necessary for amphet- 
amine reinforcement. Interestingly, recent reports exam- 
ining interactions between opiate antagonists and co- 
caine in self-administration (Carroll etal. 1986; De 
Vryet aL 1989), self-stimulation (Bain and Kornetsky 
1986), and place conditioning (Houdi et al. 1989) suggest 
that blockade of opioid receptors may interfere with the 
reinforcing actions of cocaine. It thus appears that 
opioid receptors may play a general role in the rewarding 
actions of psychomotor stimulants. These findings pro- 
vide an interesting contrast to studies which suggest that 
activation of dopamine systems is necessary for opioid 
reinforcement (Bozarth and Wise 1981; Spyraki et al. 
1983; Shippenberg and Herz 1987; Hand et al. 1989). 
Despite studies demonstrating interactions between 
opioids and catecholamines in reward, however, other 
studies have found evidence against such interactions 
(e.g. Ettenberg et al. 1982; Mackey and van der Kooy 
1985). Thus, although the evidence is not unanimous, 
the present results together with previous studies sug- 
gest that interactions between endogenous opioid and 
catecholamine systems may be important in the reinforc- 
ing actions of drugs. Further, these results hint that the 
neurochemistry of reward may be more complex than 
is currently believed. 
In conclusion, the present results suggest that activa- 
tion of opioid receptors is necessary for amphetamine's 
rewarding action. Amphetamine was observed to estab- 
lish a potent conditioned place preference which could 
be prevented by the opiate receptor antagonist naloxone. 
This action of naloxone was determined to be indepen- 
dent of aversive effects of naloxone alone, or aversive 
interactions between amphetamine and naloxone, and 
thus appears to be a specific blockade of amphetamine 
reward. These results support previous studies demon- 
strating the ability of naloxone to block amphetamine 
facilitation of self-stimulation behavior (Holtzman t976; 
Esposito et al. 1980; Leith 1982; Trujillo et al. 1983) and 
add to the increasing evidence that interactions between 
endogenous opioid and catecholamine systems are im- 
portant in reinforcement. Moreover, in light of recent 
clinical findings demonstrating the potential efficacy of 
opiate antagonists in the treatment of cocaine abuse 
(Kosten et aI. 1989) the present results are of particular 
interest, suggesting that opiate antagonists may also be 
effective pharmacological aids in the treatment of am- 
phetamine abuse. 
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